Factors affecting adherence to treatment of psoriasis: Comparing biologic therapy to other modalities

Journal of Dermatological Treatment

Volumn 24, Issue 1, 2013, Pages 64-69

  Chan, Sue Ann ^a   Hussain, Fawad ^b   Lawson, Linda G ^b   Ormerod, Anthony D ^a,b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

Adherence; Biologic therapy; Phototherapy; Psoriasis; Topical therapy

Indexed keywords

ADULT; AGED; ARTICLE; BIOLOGICAL THERAPY; CLINICAL EVALUATION; COMBINATION CHEMOTHERAPY; DERMATOLOGY LIFE QUALITY INDEX; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT SATISFACTION; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; QUESTIONNAIRE; SELF ASSESSED PSORIASIS AREA AND SEVERITY INDEX; SELF REPORT;

ADMINISTRATION, TOPICAL; ADULT; AGED; BIOLOGICAL THERAPY; COMBINED MODALITY THERAPY; DERMATOLOGIC AGENTS; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PHOTOTHERAPY; PSORIASIS; QUALITY OF LIFE; QUESTIONNAIRES; SELF DISCLOSURE; SICKNESS IMPACT PROFILE;

EID: 84872331397     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.3109/09546634.2011.607425     Document Type: Article

References (16)

1. Hayes J, Koo J. Psoriasis: depression, anxiety, smoking, and drinking habits. Dermatol Ther. 2010;23:174-180.
2. Kimball AB, Jacobson C, Weiss S, Vreeland MG, Wu Y. The psychosocial burden of psoriasis. Am J Clin Dermatol. 2005;6: 383-392.
3. Javitz HS, Ward MM, Farber E, Nail L, Vallow SG. The direct cost of care for psoriasis and psoriatic arthritis in the United States. J Am Acad Dermatol. 2002;46:850-860.
4. Bhosle MJ, Feldman SR, Camacho FT, Whitmire TJ, Nahata MC, Balkrishnan R. Medication adherence and health care costs associated with biologics in medicaid-enrolled patients with psoriasis. J Dermatolog Treat. 2006;17:294-301.
5. Smith CH, Anstey AV, Barker JN, Burden AD, Chalmers RJ, Chandler DA, et al. British association of dermatologists' guidelines for biologic interventions for psoriasis 2009. Br J Dermatol. 2009;161:987-1019.
6. Storm A, Andersen SE, Benfeldt E, et al. One in 3 prescriptions are never redeemed: primary nonadherence in an outpatient clinic. J Am Acad Dermatol. 2008;59:27-33.
7. Gokdemir G, Ari S, Koslu A. Adherence to treatment in patients with psoriasis vulgaris: Turkish experience. J Eur Acad Dermatol Venereol. 2008;22:330-335.
8. Storm A, Andersen SE, Benfeldt E, Serup J. A prospective study of patient adherence to topical treatments: 95% of patients underdose. J Am Acad Dermatol. 2008;59:975-980.
9. Van De Kerkhof PC, De Hoop D, De Korte J, Cobelens SA, Kuipers MV. Patient compliance and disease management in the treatment of psoriasis in the Netherlands. Dermatology. 2000;200:292-298.
10. Zaghloul SS, Goodfield MJ. Objective assessment of compliance with psoriasis treatment. Arch Dermatol. 2004;140: 408-414.
11. Feldman SR, Horn EJ, Balkrishnan R, Basra MK, Finlay AY, McCoy D, et al. Psoriasis: improving adherence to topical therapy. J Am Acad Dermatol. 2008;59:1009-1016.
12. Richards HL, Fortune DG, Griffiths CE. Adherence to treatment in patients with psoriasis. J Eur Acad Dermatol Venereol. 2006;20:370-379.
13. Feldman SR, Fleischer AB Jr, Reboussin DM, Rapp SR, Exum ML, Clark AR, et al. The self-administered psoriasis area and severity index is valid and reliable. J Invest Dermatol. 1996;106:183-186.
14. Fouere S, Adjadj L, Pawin H. How patients experience psoriasis: results from a European survey. J Eur Acad Dermatol Venereol. 2005; 19:2-6.
15. Carroll CL, Feldman SR, Camacho FT, Manuel JC, Balkrishnan R. Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use. J Am Acad Dermatol. 2004;51:212-216.
16. Gradwell C, Thomas KS, English JS, Williams HC. A randomized controlled trial of nurse follow-up clinics: do they help patients and do they free up consultants' time? Br J Dermatol. 2002;147:513-517.